Grey matter pathology in multiple sclerosis
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Although multiple sclerosis (MS) has been considered a white matter disease, MS lesions are known to occur in grey matter. Recent immunohistochemical studies have demonstrated extensive grey matter demyelination in chronic MS. The most common lesion type consists of purely cortical lesions extending inward from the surface of the brain, this lesion subgroup is grossly underestimated by standard histochemical myelin staining methods. Some MS patients have subpial demyelination in all cortical areas of the brain; this pattern has been termed ''general cortical subpial demyelination''. Extensive cortical demyelination is associated with the progressive phases of disease, as less cortical demyelination has been detected in relapsing-remitting MS. The pathology of grey matter lesions differs from that of white matter lesions; grey matter lesions are less inflammatory, with less macrophage and lymphocyte infiltration. In purely cortical lesions there is no significant increase in lymphocytes compared with non-demyelinated adjacent cortical areas in MS patients or cerebral cortex in control patients. Significant axonal transection and neuronal loss have been demonstrated in grey matter MS lesions. Current magnetic resonance imaging (MRI) methods are not sensitive for purely cortical MS lesions. The clinical significance of cortical MS lesions may not be characterised until more sensitive MRI methods are developed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
Polman, C. H., Reingold, S. C., Edan, G., Filippi, M., Hartung, H., Kappos, L., Lublin, F. D., Metz, L. M., McFarland, H. F., O'Connor, P. W., et al. (2005) · Annals of Neurology · doi:10.1002/ana.20703 · Cited by 5,017
Buckner, R. L., Snyder, A. Z., Shannon, B. J., LaRossa, G., Sachs, R., Fotenos, A. F., Sheline, Y. I., Klunk, W. E., Mathis, C. A., Morris, J. C., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2177-05.2005 · Cited by 2,140
Cortical demyelination and diffuse white matter injury in multiple sclerosis
Kutzelnigg, A., Lucchinetti, C. F., Stadelmann, C., Brück, W., Rauschka, H., Bergmann, M., Schmidbauer, M., Parisi, J. E., & Lassmann, H. (2005) · Brain · doi:10.1093/brain/awh641 · Cited by 1,836
Peterson, J. W., Bö, L., Mörk, S., Chang, A., & Trapp, B. D. (2001) · Annals of Neurology · doi:10.1002/ana.1123 · Cited by 1,403 · cited 5×
“Cortical lesions were classified according to a descriptive system similar to that in previous studies (5, 9).”
BackgroundResultInfluentialSelf-citationCortical lesions in multiple sclerosis
Kidd, D., Barkhof, F., McConnell, R., Algra, P. R., Allen, I. V., & Revesz, T. (1999) · Brain · doi:10.1093/brain/122.1.17 · Cited by 766 · cited 2×
“Studies using histochemical methods found the majority of cortical lesions were located at the white matter/grey matter border (6, 7).”
BackgroundSubpial Demyelination in the Cerebral Cortex of Multiple Sclerosis Patients
Bø, L., Vedeler, C. A., Nyland, H. I., Trapp, B. D., & Mørk, S. J. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.7.723 · Cited by 757 · cited 4×
“(2003) studied the extent and distribution of grey matter demyelination in MS by myelin basic protein (MBP) immunohistochemistry, in a material of brains from 20 chronic MS patients, obtained at autopsy (8).”
BackgroundInfluentialSelf-citationThe peripheral benzodiazepine binding site in the brain in multiple sclerosis
Banati, R. B., Newcombe, J., Gunn, R. N., Cagnin, A., Turkheimer, F., Heppner, F., Price, G., Wegner, F., Giovannoni, G., Miller, D. H., et al. (2000) · Brain · doi:10.1093/brain/123.11.2321 · Cited by 661
Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration
Bø, L., Vedeler, C. A., Nyland, H., Trapp, B. D., & Mørk, S. J. (2003) · Multiple Sclerosis Journal · doi:10.1191/1352458503ms917oa · Cited by 478
Self-citationEarly frontotemporal dementia targets neurons unique to apes and humans
Seeley, W. W., Carlin, D. A., Allman, J. M., Macedo, M. N., Bush, C., Miller, B. L., & DeArmond, S. J. (2006) · Annals of Neurology · doi:10.1002/ana.21055 · Cited by 364
Structural brain abnormalities in multiple sclerosis patients with major depression
Feinstein, A., Roy, P., Lobaugh, N., Feinstein, K., O’Connor, P., & Black, S. (2004) · Neurology · doi:10.1212/01.wnl.0000110316.12086.0c · Cited by 294
Cited by
Dynamics of oligodendrocyte generation in multiple sclerosis
Yeung, M. S. Y., Djelloul, M., Steiner, E., Bernard, S., Salehpour, M., Possnert, G., Brundin, L., & Frisén, J. (2019) · Nature · doi:10.1038/s41586-018-0842-3 · Cited by 376
Luchetti, S., Fransen, N. L., van Eden, C. G., Ramaglia, V., Mason, M., & Huitinga, I. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1818-y · Cited by 355
The cuprizone model for demyelination
Torkildsen, Ø., Brunborg, L. A., Myhr, K.-M., & Bø, L. (2008) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2008.01036.x · Cited by 346
Self-citationRadical changes in multiple sclerosis pathogenesis
van Horssen, J., Witte, M. E., Schreibelt, G., & de Vries, H. E. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.06.011 · Cited by 322
Oxidative stress in multiple sclerosis: Central and peripheral mode of action
Ohl, K., Tenbrock, K., & Kipp, M. (2016) · Experimental Neurology · doi:10.1016/j.expneurol.2015.11.010 · Cited by 317
Brain Extracellular Matrix in Neurodegeneration
Bonneh‐Barkay, D., & Wiley, C. A. (2009) · Brain Pathology · doi:10.1111/j.1750-3639.2008.00195.x · Cited by 307
Inflammatory intrathecal profiles and cortical damage in multiple sclerosis
Magliozzi, R., Howell, O. W., Nicholas, R., Cruciani, C., Castellaro, M., Romualdi, C., Rossi, S., Pitteri, M., Benedetti, M. D., Gajofatto, A., et al. (2018) · Annals of Neurology · doi:10.1002/ana.25197 · Cited by 298
Mitochondrial dysfunction contributes to neurodegeneration in multiple sclerosis
Witte, M. E., Mahad, D. J., Lassmann, H., & van Horssen, J. (2014) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2013.11.007 · Cited by 278
The neuropathological basis of clinical progression in multiple sclerosis
Reynolds, R., Roncaroli, F., Nicholas, R., Radotra, B., Gveric, D., & Howell, O. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0840-0 · Cited by 221
“Other differences between cortical and WM demyelination include the lack of significant leakage of plasma proteins, suggesting a preserved BBB, the absence of significant signs of complement activation and the presence of an increased number of activated microglial cells, suggesting a role for these cells in modulatin…”
BackgroundHippocampal CA1 atrophy and synaptic loss during experimental autoimmune encephalomyelitis, EAE
Ziehn, M. O., Avedisian, A. A., Tiwari-Woodruff, S., & Voskuhl, R. R. (2010) · Laboratory Investigation · doi:10.1038/labinvest.2010.6 · Cited by 189
The blood-brain barrier in cortical multiple sclerosis lesions
van Horssen, J., Brink, B. P., de Vries, H. E., van der Valk, P., & Bø, L. (2007) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318040b2de · Cited by 187
Self-citationMechanisms of Neurodegeneration and Axonal Dysfunction in Progressive Multiple Sclerosis
Correale, J., Marrodan, M., & Ysrraelit, M. C. (2019) · Biomedicines · doi:10.3390/biomedicines7010014 · Cited by 167
Improved detection of cortical MS lesions with phase-sensitive inversion recovery MRI
Sethi, V., Yousry, T. A., Muhlert, N., Ron, M., Golay, X., Wheeler-Kingshott, C., Miller, D. H., & Chard, D. T. (2012) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-303023 · Cited by 163
Cerebellar Cortical Demyelination in the Murine Cuprizone Model
Skripuletz, T., Bussmann, J., Gudi, V., Koutsoudaki, P. N., Pul, R., Moharregh‐Khiabani, D., Lindner, M., & Stangel, M. (2010) · Brain Pathology · doi:10.1111/j.1750-3639.2009.00271.x · Cited by 108
P2Y12 receptor protein in cortical gray matter lesions in multiple sclerosis.
Amadio, S., Montilli, C., Magliozzi, R., Bernardi, G., Reynolds, R., & Volonte, C. (2010) · Cerebral Cortex · doi:10.1093/cercor/bhp193 · Cited by 73
Redefining functionality and treatment efficacy in multiple sclerosis
Foley, J. F., & Brandes, D. W. (2009) · Neurology · doi:10.1212/wnl.0b013e3181a99bc2 · Cited by 34
Dang, A. K., Jain, R. W., Craig, H. C., & Kerfoot, S. M. (2015) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2014.12.008 · Cited by 31
Lesion Expansion in Experimental Demyelination Animal Models and Multiple Sclerosis Lesions
Große-Veldmann, R., Becker, B., Amor, S., van der Valk, P., Beyer, C., & Kipp, M. (2016) · Molecular Neurobiology · doi:10.1007/s12035-015-9420-y · Cited by 18
Metadata
- Authors
- Bo, L., Geurts, J. J. G., Mork, S. J., & Valk, P.
- Venue
- Acta Neurologica Scandinavica
- Publisher
- Hindawi Limited
- Published
- 2006-05
- Volume
- 113
- Issue
- s183
- Pages
- 48-50
- ISSN
- 0001-6314 (ISSN-L)
- 1600-0404
- OpenAlex
- W2151651656
- Cited by
- 148
- References
- 14
- FWCI
- 7.50
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.